Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Cingulo-hippocampal effective connectivity positively correlates with drug-cue attentional bias in opioid use disorder.

Ma L, Steinberg JL, Bjork JM, Taylor BA, Arias AJ, Terplan M, Anastasio NC, Zuniga EA, Lennon M, Cunningham KA, Moeller FG.

Psychiatry Res Neuroimaging. 2019 Aug 13. pii: S0925-4927(19)30026-5. doi: 10.1016/j.pscychresns.2019.08.005. [Epub ahead of print]

PMID:
31439409
2.

The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection.

Edwards VL, Smith SB, McComb EJ, Tamarelle J, Ma B, Humphrys MS, Gajer P, Gwilliam K, Schaefer AM, Lai SK, Terplan M, Mark KS, Brotman RM, Forney LJ, Bavoil PM, Ravel J.

MBio. 2019 Aug 13;10(4). pii: e01548-19. doi: 10.1128/mBio.01548-19.

3.

Cognitive and Behavioral Impact on Children Exposed to Opioids During Pregnancy.

Larson JJ, Graham DL, Singer LT, Beckwith AM, Terplan M, Davis JM, Martinez J, Bada HS.

Pediatrics. 2019 Aug;144(2). pii: e20190514. doi: 10.1542/peds.2019-0514. Epub 2019 Jul 18.

PMID:
31320466
4.

National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women With Opioid Use Disorder.

Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S, Leffert LR, Main EK, Mitchell KT, OʼGurek DT, DʼOria R, McDaniel D, Terplan M.

Obstet Gynecol. 2019 Aug;134(2):365-375. doi: 10.1097/AOG.0000000000003381.

PMID:
31306323
5.

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer.

Rubinsak LA, Terplan M, Martin CE, Fields EC, McGuire WP, Temkin SM.

Gynecol Oncol Rep. 2019 Mar 27;28:116-119. doi: 10.1016/j.gore.2019.03.016. eCollection 2019 May.

6.

Rates of and Factors Associated With Patient-reported Illicit Drug Use Screening by Health Care Professionals in the United States From 2013 to 2015.

Scialli AC, Terplan M.

J Addict Med. 2019 Apr 2. doi: 10.1097/ADM.0000000000000537. [Epub ahead of print]

PMID:
30946091
7.

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine.

Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA.

Am J Obstet Gynecol. 2019 Jul;221(1):B5-B28. doi: 10.1016/j.ajog.2019.03.022. Epub 2019 Mar 27. No abstract available.

PMID:
30928567
8.

Screening for substance use in pregnancy and the newborn.

Polak K, Kelpin S, Terplan M.

Semin Fetal Neonatal Med. 2019 Apr;24(2):90-94. doi: 10.1016/j.siny.2019.01.007. Epub 2019 Feb 5. Review.

PMID:
30770326
9.

Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder.

Peeler M, Fiscella K, Terplan M, Sufrin C.

J Correct Health Care. 2019 Jan;25(1):4-14. doi: 10.1177/1078345818819855. Epub 2019 Jan 7.

PMID:
30616487
10.

Contraceptive utilization among new exotic dancers: a cross-sectional study.

Terplan M, Martin CE, Nail J, Sherman SG.

Harm Reduct J. 2018 Nov 12;15(1):56. doi: 10.1186/s12954-018-0261-7.

11.

Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs.

MacAfee LK, Dalton V, Terplan M.

J Addict Med. 2019 May/Jun;13(3):177-181. doi: 10.1097/ADM.0000000000000471.

PMID:
30394994
12.

Racial and Ethnic Disparities in the Incidence of Severe Maternal Morbidity in the United States, 2012-2015.

Admon LK, Winkelman TNA, Zivin K, Terplan M, Mhyre JM, Dalton VK.

Obstet Gynecol. 2018 Nov;132(5):1158-1166. doi: 10.1097/AOG.0000000000002937.

PMID:
30303912
13.

In Reply.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 Oct;132(4):1061-1062. doi: 10.1097/AOG.0000000000002885. No abstract available.

PMID:
30247340
14.

Pregnancy and Naltrexone Pharmacotherapy.

Jones CW, Terplan M.

Obstet Gynecol. 2018 Oct;132(4):923-925. doi: 10.1097/AOG.0000000000002864.

PMID:
30204703
15.

Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.

Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley AY, Land T.

Obstet Gynecol. 2018 Aug;132(2):466-474. doi: 10.1097/AOG.0000000000002734.

16.

Pregnancy intention and opioid use disorder treatment retention in the MOTHER study.

Martin CE, Terplan M, O'Grady KE, Jones HE.

Am J Addict. 2018 Jul 11. doi: 10.1111/ajad.12735. [Epub ahead of print]

PMID:
29995313
17.

Characteristics of Pregnant Women Reporting Cannabis Use Disorder at Substance Use Treatment Entry.

Washio Y, Mark K, Terplan M.

J Addict Med. 2018 Sep/Oct;12(5):395-400. doi: 10.1097/ADM.0000000000000424.

PMID:
29864087
18.

Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.

Short VL, Hand DJ, MacAfee L, Abatemarco DJ, Terplan M.

J Subst Abuse Treat. 2018 Jun;89:67-74. doi: 10.1016/j.jsat.2018.04.003. Epub 2018 Apr 6.

PMID:
29706175
19.

Opioid Detoxification During Pregnancy: A Systematic Review.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 May;131(5):803-814. doi: 10.1097/AOG.0000000000002562.

20.

The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice.

Murphy J, Goodman D, Johnson MC, Terplan M.

Obstet Gynecol. 2018 Mar;131(3):542-544. doi: 10.1097/AOG.0000000000002493.

PMID:
29420414
21.

Maternal Health in the United States.

Schiff DM, Patrick SW, Terplan M.

N Engl J Med. 2018 Feb 8;378(6):587. doi: 10.1056/NEJMc1715957. No abstract available.

PMID:
29419278
22.

A Pilot Randomized Controlled Trial of a Phone-based Intervention for Smoking Cessation and Relapse Prevention in the Postpartum Period.

Coleman-Cowger VH, Mark KS, Rosenberry ZR, Koszowski B, Terplan M.

J Addict Med. 2018 May/Jun;12(3):193-200. doi: 10.1097/ADM.0000000000000385.

23.

Risk of complication during surgical abortion in obese women.

Mark KS, Bragg B, Talaie T, Chawla K, Murphy L, Terplan M.

Am J Obstet Gynecol. 2018 Feb;218(2):238.e1-238.e5. doi: 10.1016/j.ajog.2017.10.018. Epub 2017 Oct 24.

PMID:
29074080
24.

Characteristics of pregnant women who reported alcohol use at admission to substance use treatment.

Washio Y, E Martin C, Goldstein ND, Terplan M.

J Subst Abuse Treat. 2017 Nov;82:82-86. doi: 10.1016/j.jsat.2017.09.010. Epub 2017 Sep 15.

PMID:
29021120
25.

Re: Neonatal Abstinence Syndrome and High School Performance.

Terplan M, Patrick S, Jansson LM.

Pediatrics. 2017 Jun;139(6). pii: e20170972A. doi: 10.1542/peds.2017-0972A. No abstract available.

26.

Women and the opioid crisis: historical context and public health solutions.

Terplan M.

Fertil Steril. 2017 Aug;108(2):195-199. doi: 10.1016/j.fertnstert.2017.06.007. Epub 2017 Jul 8. Review.

PMID:
28697909
27.

Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization.

Mark K, Terplan M.

Prev Med. 2017 Nov;104:46-49. doi: 10.1016/j.ypmed.2017.05.012. Epub 2017 May 18.

PMID:
28528172
28.

Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome.

Terplan M.

J Addict Med. 2017 May/Jun;11(3):176-177. doi: 10.1097/ADM.0000000000000309.

PMID:
28406855
29.

Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm.

Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M.

J Addict Med. 2017 May/Jun;11(3):211-216. doi: 10.1097/ADM.0000000000000299.

PMID:
28252456
30.

Opioid detoxification during pregnancy needs to be grounded in addiction science.

Terplan M.

Am J Obstet Gynecol. 2017 Jun;216(6):623. doi: 10.1016/j.ajog.2017.02.030. Epub 2017 Feb 22. No abstract available.

PMID:
28235462
31.

Medically Assisted Withdrawal (Detoxification): Considering the Mother-Infant Dyad.

Jones HE, Terplan M, Meyer M.

J Addict Med. 2017 Mar/Apr;11(2):90-92. doi: 10.1097/ADM.0000000000000289.

PMID:
28079573
32.

Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs.

Terplan M, Minkoff H.

Obstet Gynecol. 2017 Jan;129(1):164-167. doi: 10.1097/AOG.0000000000001781.

PMID:
27926654
33.

The role of screening, brief intervention, and referral to treatment in the perinatal period.

Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA.

Am J Obstet Gynecol. 2016 Nov;215(5):539-547. doi: 10.1016/j.ajog.2016.06.038. Epub 2016 Jul 1. Review.

PMID:
27373599
34.

Detoxification from opiates during pregnancy: stressing the fetal brain.

McCarthy JJ, Terplan M.

Am J Obstet Gynecol. 2016 Nov;215(5):670.e1-670.e2. doi: 10.1016/j.ajog.2016.05.041. Epub 2016 Jun 2. No abstract available.

PMID:
27262972
35.

Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.

Premkumar A, Terplan M.

Obstet Gynecol. 2016 Nov;128(5):1179. No abstract available.

PMID:
27776054
36.

Family Planning in Substance Use Disorder Treatment Centers: Opportunities and Challenges.

Robinowitz N, Muqueeth S, Scheibler J, Salisbury-Afshar E, Terplan M.

Subst Use Misuse. 2016 Sep 18;51(11):1477-83. doi: 10.1080/10826084.2016.1188944. Epub 2016 Jul 20.

PMID:
27440391
37.

Breast Implants, Self-Esteem, Quality of Life, and the Risk of Suicide.

Zuckerman DM, Kennedy CE, Terplan M.

Womens Health Issues. 2016 Jul-Aug;26(4):361-5. doi: 10.1016/j.whi.2016.03.002. Epub 2016 Apr 16. No abstract available.

PMID:
27094911
38.

Reproductive Health Needs Among Substance Use Disorder Treatment Clients.

Terplan M, Lawental M, Connah MB, Martin CE.

J Addict Med. 2016 Jan-Feb;10(1):20-5. doi: 10.1097/ADM.0000000000000175.

PMID:
26690290
39.

Factors Associated with Early Pregnancy Smoking Status Among Low-Income Smokers.

Coleman-Cowger VH, Koszowski B, Rosenberry ZR, Terplan M.

Matern Child Health J. 2016 May;20(5):1054-60. doi: 10.1007/s10995-015-1891-y.

40.

Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness.

Terplan M, Kennedy-Hendricks A, Chisolm MS.

Subst Abuse. 2015 Sep 20;9(Suppl 2):1-4. doi: 10.4137/SART.S23328. eCollection 2015.

41.

Trends in Relative Survival for Ovarian Cancer From 1975-2011.

Temkin SM, Terplan M.

Obstet Gynecol. 2015 Oct;126(4):898. doi: 10.1097/AOG.0000000000001073. No abstract available.

PMID:
26393445
42.

Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.

Terplan M, Longinaker N, Appel L.

Am J Public Health. 2015 Nov;105(11):e50-4. doi: 10.2105/AJPH.2015.302821. Epub 2015 Sep 17.

43.

In reply.

Cheng D, Salimi S, Terplan M, Chisolm MS.

Obstet Gynecol. 2015 Jun;125(6):1493-4. doi: 10.1097/AOG.0000000000000877. No abstract available.

44.

Knowledge, Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women.

Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M.

J Addict Med. 2015 Jul-Aug;9(4):266-72. doi: 10.1097/ADM.0000000000000128.

PMID:
25974378
45.

Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH.

Prev Med. 2015 Nov;80:23-31. doi: 10.1016/j.ypmed.2015.04.008. Epub 2015 Apr 18. Review.

46.

Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes.

Mark K, Desai A, Terplan M.

Arch Womens Ment Health. 2016 Feb;19(1):105-11. doi: 10.1007/s00737-015-0529-9. Epub 2015 Apr 19.

PMID:
25895138
47.

The Relationship Between Postpartum Depression and Perinatal Cigarette Smoking: An Analysis of PRAMS Data.

Salimi S, Terplan M, Cheng D, Chisolm MS.

J Subst Abuse Treat. 2015 Sep;56:34-8. doi: 10.1016/j.jsat.2015.03.004. Epub 2015 Mar 25.

48.

Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.

Terplan M, Ramanadhan S, Locke A, Longinaker N, Lui S.

Cochrane Database Syst Rev. 2015 Apr 2;(4):CD006037. doi: 10.1002/14651858.CD006037.pub3. Review.

49.

Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.

Temkin SM, Fleming SA, Amrane S, Schluterman N, Terplan M.

Gynecol Oncol. 2015 Jun;137(3):497-502. doi: 10.1016/j.ygyno.2015.03.010. Epub 2015 Mar 17.

PMID:
25795262
50.

Demystifying electronic cigarette use in pregnancy.

Farquhar B, Mark K, Terplan M, Chisolm MS.

J Addict Med. 2015 Mar-Apr;9(2):157-8. doi: 10.1097/ADM.0000000000000100.

PMID:
25622121

Supplemental Content

Loading ...
Support Center